PetVivo Holdings, Inc., an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices and therapeutics for pets, closed its previously announced underwritten public offering of 2,500,000 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock.
August 13, 2021
· 4 min read